ICON Price to Sales Ratio 2010-2025 | ICLR
Historical PS ratio values for ICON (ICLR) over the last 10 years. The current P/S ratio for ICON as of June 27, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| ICON P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-06-27 | 144.56 | 1.46 | |
| 2025-03-31 | 174.99 | $99.07 | 1.77 |
| 2024-12-31 | 209.71 | $99.45 | 2.11 |
| 2024-09-30 | 287.31 | $99.85 | 2.88 |
| 2024-06-30 | 313.47 | $100.29 | 3.13 |
| 2024-03-31 | 335.95 | $99.31 | 3.38 |
| 2023-12-31 | 283.07 | $98.15 | 2.88 |
| 2023-09-30 | 246.25 | $96.96 | 2.54 |
| 2023-06-30 | 250.20 | $95.74 | 2.61 |
| 2023-03-31 | 213.59 | $94.80 | 2.25 |
| 2022-12-31 | 194.25 | $93.87 | 2.07 |
| 2022-09-30 | 183.78 | $97.77 | 1.88 |
| 2022-06-30 | 216.70 | $97.33 | 2.23 |
| 2022-03-31 | 243.22 | $90.14 | 2.70 |
| 2021-12-31 | 309.70 | $83.22 | 3.72 |
| 2021-09-30 | 262.02 | $69.79 | 3.75 |
| 2021-06-30 | 206.71 | $59.88 | 3.45 |
| 2021-03-31 | 196.37 | $55.25 | 3.55 |
| 2020-12-31 | 194.98 | $52.42 | 3.72 |
| 2020-09-30 | 191.09 | $51.51 | 3.71 |
| 2020-06-30 | 168.46 | $51.34 | 3.28 |
| 2020-03-31 | 136.00 | $52.41 | 2.60 |
| 2019-12-31 | 172.23 | $51.61 | 3.34 |
| 2019-09-30 | 147.34 | $50.65 | 2.91 |
| 2019-06-30 | 153.97 | $49.56 | 3.11 |
| 2019-03-31 | 136.58 | $48.49 | 2.82 |
| 2018-12-31 | 129.21 | $47.30 | 2.73 |
| 2018-09-30 | 153.75 | $43.20 | 3.56 |
| 2018-06-30 | 132.53 | $39.31 | 3.37 |
| 2018-03-31 | 118.14 | $35.52 | 3.33 |
| 2017-12-31 | 112.15 | $32.04 | 3.50 |
| 2017-09-30 | 113.88 | $31.46 | 3.62 |
| 2017-06-30 | 97.79 | $30.84 | 3.17 |
| 2017-03-31 | 79.72 | $30.19 | 2.64 |
| 2016-12-31 | 75.20 | $29.51 | 2.55 |
| 2016-09-30 | 77.37 | $28.49 | 2.72 |
| 2016-06-30 | 70.01 | $27.61 | 2.54 |
| 2016-03-31 | 75.10 | $26.64 | 2.82 |
| 2015-12-31 | 77.70 | $25.79 | 3.01 |
| 2015-09-30 | 70.97 | $25.40 | 2.79 |
| 2015-06-30 | 67.30 | $24.98 | 2.69 |
| 2015-03-31 | 70.53 | $24.62 | 2.86 |
| 2014-12-31 | 50.99 | $23.88 | 2.14 |
| 2014-09-30 | 57.23 | $23.07 | 2.48 |
| 2014-06-30 | 47.11 | $22.40 | 2.10 |
| 2014-03-31 | 47.55 | $21.86 | 2.17 |
| 2013-12-31 | 40.42 | $23.17 | 1.74 |
| 2013-09-30 | 40.93 | $22.61 | 1.81 |
| 2013-06-30 | 35.43 | $21.90 | 1.62 |
| 2013-03-31 | 32.29 | $21.07 | 1.53 |
| 2012-12-31 | 27.76 | $19.89 | 1.40 |
| 2012-09-30 | 24.37 | $18.94 | 1.29 |
| 2012-06-30 | 22.53 | $18.16 | 1.24 |
| 2012-03-31 | 21.22 | $17.40 | 1.22 |
| 2011-12-31 | 17.11 | $16.76 | 1.02 |
| 2011-09-30 | 16.08 | $16.58 | 0.97 |
| 2011-06-30 | 23.56 | $16.35 | 1.44 |
| 2011-03-31 | 21.59 | $16.21 | 1.33 |
| 2010-12-31 | 21.90 | $16.34 | 1.34 |
| 2010-09-30 | 21.62 | $16.30 | 1.33 |
| 2010-06-30 | 28.89 | $16.27 | 1.78 |
| 2010-03-31 | 26.41 | $16.28 | 1.62 |
| 2009-12-31 | 21.73 | $14.82 | 1.47 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $11.851B | $8.282B |
| ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $144.179B | 27.04 |
| CVS Health (CVS) | United States | $86.198B | 10.71 |
| Elevance Health (ELV) | United States | $84.314B | 10.88 |
| Cencora (COR) | United States | $57.484B | 20.00 |
| DiDi Global (DIDIY) | China | $23.485B | 24.95 |
| Natera (NTRA) | United States | $22.963B | 0.00 |
| Labcorp Holdings (LH) | United States | $21.509B | 17.45 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.205B | 0.00 |
| Solventum (SOLV) | United States | $12.912B | 13.67 |
| CochLear (CHEOY) | Australia | $12.870B | 0.00 |
| Revvity (RVTY) | United States | $11.644B | 20.04 |
| Viatris (VTRS) | United States | $10.704B | 3.68 |
| Avantor (AVTR) | United States | $9.363B | 13.60 |
| HealthEquity (HQY) | United States | $9.068B | 39.72 |
| Medpace Holdings (MEDP) | United States | $8.818B | 23.42 |
| Sonic Healthcare (SKHHY) | Australia | $8.465B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.445B | 14.59 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.269B | 25.15 |
| BrightSpring Health Services (BTSG) | United States | $4.058B | 37.23 |
| Sotera Health (SHC) | United States | $3.225B | 18.32 |
| Surgery Partners (SGRY) | United States | $2.781B | 36.17 |
| Alignment Healthcare (ALHC) | United States | $2.722B | 0.00 |
| Concentras Parent (CON) | United States | $2.652B | 15.33 |
| Organon (OGN) | United States | $2.594B | 2.76 |
| GeneDx Holdings (WGS) | United States | $2.556B | 98.45 |
| PACS (PACS) | United States | $1.958B | 0.00 |
| Ardent Health (ARDT) | United States | $1.904B | 8.12 |
| Progyny (PGNY) | United States | $1.840B | 40.49 |
| Premier (PINC) | United States | $1.796B | 13.63 |
| GoodRx Holdings (GDRX) | United States | $1.761B | 35.21 |
| Teladoc Health (TDOC) | United States | $1.412B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.181B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.171B | 8.91 |
| CareDx (CDNA) | United States | $1.074B | 16.77 |
| Agilon Health (AGL) | United States | $0.956B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.919B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.840B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.806B | 7.54 |
| Nutex Health (NUTX) | United States | $0.658B | 9.96 |
| LifeMD (LFMD) | United States | $0.615B | 0.00 |
| Embecta (EMBC) | United States | $0.542B | 3.65 |
| InnovAge Holding (INNV) | United States | $0.532B | 0.00 |
| Enhabit (EHAB) | United States | $0.482B | 39.62 |
| Auna S.A (AUNA) | Luxembourg | $0.470B | 10.58 |
| SBC Medicals (SBC) | United States | $0.464B | 0.00 |
| Omada Health (OMDA) | $0.460B | 0.00 | |
| Sonida Senior Living (SNDA) | United States | $0.459B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.312B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.249B | 0.00 |
| Beauty Health (SKIN) | United States | $0.244B | 0.00 |
| So-Young (SY) | China | $0.209B | 0.00 |
| Oncology Institute (TOI) | United States | $0.200B | 0.00 |
| DocGo (DCGO) | United States | $0.172B | 28.17 |
| Pheton Holdings (PTHL) | China | $0.115B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.096B | 0.00 |
| KindlyMD (NAKA) | United States | $0.089B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.075B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| ModivCare (MODV) | United States | $0.051B | 0.00 |
| Biodesix (BDSX) | United States | $0.041B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.036B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.033B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |